Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
166.8 USD | +1.16% | -0.14% | -7.22% |
05-02 | UBS Adjusts Price Target on Repligen to $205 From $225, Maintains Buy Rating | MT |
05-01 | Repligen's Q1 Adjusted Earnings, Revenue Fall | MT |
MarketScreener Editorial Features
Powell's mixed signals and Pacwest weigh on US indices | May 04, 2023 at 02:20 pm | |
ANALYST RECOMMENDATIONS : AMD, Avis, Clorox, Flutter, Starbucks... | May 04, 2023 at 10:50 am | |
Markets are at a crossroads | February 23, 2023 at 01:58 pm | |
ANALYST RECOMMENDATIONS : BP, Centene, Experian, Intel, Walgreens... | February 23, 2023 at 10:36 am | |
Recession ahead | December 07, 2022 at 03:17 pm | |
ANALYST RECOMMANDATIONS : Dominion Energy, Expedia, Repligen, TripAdvisor... | December 07, 2022 at 11:29 am | |
These five stock are rare gems | August 19, 2022 at 02:14 pm | |
Lost in inflation | August 08, 2022 at 01:56 pm | |
ANALYST RECOMMENDATIONS : Cigna, Duke Energy, Vertex Pharmaceuticals, EOG Resources, Motorola Solutions... | August 08, 2022 at 10:47 am | |
A couple of hopes dashed | August 03, 2022 at 01:56 pm | |
ANALYST RECOMMENDATIONS : Advanced Micro Devices, Uber, SBA Communications, Global Payments, Simon Property... | August 03, 2022 at 10:48 am |
- Stock Market
- Equities
- RGEN Stock
- News Repligen Corporation
- MarketScreener Editorial Features